COVID vaccine 73.2 percent effective in children under 5: Pfizer Ruchika Sharma24 Aug 2022 4:30 PM ISTThe Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech's proprietary mRNA technology, was developed by both BioNTech and Pfizer.
Pfizer, BioNTech seek USFDA emergency use nod for Omicron adapted COVID booster dose for 12 years of age and older Ruchika Sharma23 Aug 2022 11:32 AM ISTThe bivalent vaccine contains mRNA encoding the original SARS-CoV-2 spike protein, which is present in the original Pfizer-BioNTech COVID-19 Vaccine,...
Pfizer COVID booster gets Canadian nod for kids 5-11 Ruchika Sharma20 Aug 2022 10:30 AM ISTOttawa: Canada's health ministry on Friday said it had authorized the use of Pfizer Inc's and BioNTech's COVID-19 vaccine as a booster for children...
Pfizer CEO Albert Bourla tests COVID positive Ruchika Sharma16 Aug 2022 3:39 PM ISTNew York: Pfizer Inc Chief Executive Officer Albert Bourla has said that he had tested positive for COVID-19 and was experiencing very mild...
BioNTech expects to begin Omicron-adapted vaccine deliveries as soon as October Ruchika Sharma12 Aug 2022 5:45 PM ISTBerlin: BioNTech expects to begin deliveries of two Omicron-adapted vaccines as soon as October, which will help spur demand in the fourth...
EMA starts rolling review of Pfizer-BioNTech variant-adapted COVID vaccine Ruchika Sharma11 Aug 2022 3:45 PM ISTNew Delhi: The European Medicines Agency (EMA) has started a rolling review of a variant-adapted COVID-19 vaccine from Pfizer and BioNTech, it said on...
Sinovac COVID vaccine approved for toddlers in Hong Kong Ruchika Sharma2 Aug 2022 4:03 PM ISTThe government said it was also negotiating with China's Fosun, which supplies Germany's BioNtech vaccine, to purchase a formula of that vaccine for...
Pfizer leaves COVID product forecast unchanged Ruchika Sharma29 July 2022 12:38 PM ISTPfizer has been banking on sales of vaccine booster doses, including an Omicron-tailored version expected in the fall, to drive demand in the next few...
BioNTech, Pfizer sue CureVac in US over COVID jab patent claims Rahul Verma27 July 2022 6:00 PM ISTCOVID-19 vaccine maker BioNTech said on Tuesday that it and partner Pfizer have filed a complaint with the U.S. District Court in Massachusetts,...
Pfizer, BioNTech sue CureVac in US over COVID vaccine patent claims Ruchika Sharma27 July 2022 4:44 PM ISTFrankfurt: COVID-19 vaccine maker BioNTech said on Tuesday that it and partner Pfizer have filed a complaint with the U.S. District Court in...
Pfizer, BioNTech submit variation to EMA for vaccination of children 6 months to less than 5 years with COMIRNATY Ruchika Sharma11 July 2022 4:27 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that the companies have submitted a variation to the European Medicines Agency...
Pfizer-BioNTech gets USFDA nod for COVID vaccine Comirnaty for adolescents 12 through 15 years of age Ruchika Sharma9 July 2022 1:45 PM ISTCOMIRNATY (COVID-19 Vaccine, mRNA) is a vaccine approved for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute...
